Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00324558
Recruitment Status : Terminated (Sponsor stopped due to difficulties to recruit 130 patients required by protocol)
First Posted : May 11, 2006
Last Update Posted : June 8, 2012
Information provided by (Responsible Party):
Clinica Universidad de Navarra, Universidad de Navarra